In a significant development for investors, Kahn Swick & Foti, LLC (KSF), a prominent securities litigation firm, is alerting shareholders of Reckitt Benckiser Group PLC (RBGLY) regarding an upcoming legal deadline in a class action lawsuit initiated against the company. Specifically, those who experienced losses exceeding $100,000 during the defined trading period from January 13, 2021, to July 28, 2024, are urged to take action before the lead plaintiff application deadline on August 4, 2025.
The Situation at Hand
Former Louisiana Attorney General, Charles C. Foti, Jr., now a partner at KSF, emphasizes the importance of this case, which is currently pending in the United States District Court for the Southern District of New York. He invites affected shareholders to get in touch to discuss their legal rights and potential pathways for seeking recovery. Essentially, this initiative addresses those who purchased American Depositary Shares (ADSs) of Reckitt during the class period and are looking to understand how the lawsuit might impact their financial recovery strategies.
What Are the Allegations?
The core of the lawsuit revolves around allegations that Reckitt and certain executives failed to disclose essential material information that could affect investors’ decisions. The claims argue that the company misled the market regarding the safety and risks associated with its cow's milk-based baby formula, Enfamil. Specifically, one crucial point is the assertion that preterm infants consuming this product faced an increased risk of necrotizing enterocolitis (NEC).
In addition, it is alleged that Reckitt's optimistic statements about its performance and prospects were grossly inaccurate and baseless given the undisclosed risks associated with its products. This negligence could manifest in significant legal repercussions for the company, affecting its stock performance and the financial well-being of its investors.
How to Proceed
For investors who bought into Reckitt Benckiser and aim to explore their options regarding participation in this class action, KSF provides a risk-free point of contact. Interested parties are encouraged to reach out to Lewis Kahn, KSF’s Managing Partner, to discuss the intricacies of their situation. Investors can contact him toll-free at 1-877-515-1850 or submit inquiries via email at
email protected]. Additionally, they are encouraged to visit KSF's website at [ksfcounsel.com for further details.
About Kahn Swick & Foti, LLC
Kahn Swick & Foti, known for championing the rights of investors, stands out as one of the nation's premier boutique securities litigation law firms. With a keen focus on helping public and private institutional investors, alongside retail investors, KSF is committed to recovering losses stemming from corporate fraud or misconduct by publicly traded companies. Ranking among the top firms nationally based on settlement values underscores their dedication and success in this realm.
The firm maintains multiple offices across major cities, including New York, Delaware, Chicago, and California, allowing it to serve a broad client base effectively. For those with substantial investments in Reckitt, staying informed and proactively engaging with legal opportunities is essential during this challenging time for the company.
In conclusion, Reckitt Benckiser shareholders with significant financial losses during the specified trading period should act promptly to ensure their voices are heard in this pivotal class action lawsuit. The looming deadline brings urgency to the situation, yet it also offers an opportunity for affected investors to seek justice and recovery with the assistance of legal experts.